Kamada Ltd
KMDA
Market Cap$384.71M
Close$
$10.10
56% upside
Current Fair Value
56% upsideUndervalued by 56% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $384.71 Million |
|---|---|
| Enterprise Value | $317.51 Million |
| Dividend Yield | $0.19982 (2.98684603886398%) |
| Earnings per Share | $0.26 |
| Beta | 0.28 |
| Outstanding Shares | 54,400,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 25.16 |
|---|---|
| PEG | 126.73 |
| Price to Sales | 3.24 |
| Price to Book Ratio | 1.62 |
| Enterprise Value to Revenue | 1.99 |
| Enterprise Value to EBIT | 19.13 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Kamada Ltd
316 employees
CEO: Amir London Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, an...